Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05215574 |
| Title | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NGM Biopharmaceuticals, Inc |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| NGM Clinical Study Site | Gilbert | Arizona | 85234 | United States | Details | |
| NGM Clinical Study Site | Los Angeles | California | 90025 | United States | Details | |
| NGM Clinical Study Site | Sarasota | Florida | 34232 | United States | Details | |
| NGM Clinical Study Site | Tampa | Florida | 33612 | United States | Details | |
| NGM Clinical Study Site | Grand Rapids | Michigan | 49546 | United States | Details | |
| NGM Clinical Study Site | New York | New York | 10016 | United States | Details | |
| NGM Clinical Study Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| NGM Clinical Study Site | Austin | Texas | 78758 | United States | Details | |
| NGM Clinical Study Site | Houston | Texas | 77030 | United States | Details |